Cintapro OD
Cintapro-OD Tablet is a prescription medicine used in the treatment of gastroesophageal reflux disease (acid reflux) and indigestion. This medicine indirectly stimulates the release of a chemical messenger that increases motility of the intestine.
Cintapro-OD Tablet is taken after meals in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends. If you stop treatment too early your symptoms may come back and your condition may worsen. Let your doctor know about all other medications you are taking as some may affect, or be affected by this medicine.
The most common side effects are headache and nausea. Most of these are temporary and usually resolve with time. Contact your doctor straight away if you are at all concerned about any of these side effects. This medicine may cause diarrhea, so its better to take plenty of fluids while taking this medicine as it may help to prevent dehydration.
Before taking it, you should tell your doctor if you have any kidney or liver diseases so that your doctor can prescribe a suitable dose for you. Pregnant or breastfeeding women should also consult their doctor.
USES OF CINTAPRO-OD TABLET ER
- Gastroesophageal reflux disease (Acid reflux)
- Indigestion
BENEFITS OF CINTAPRO-OD TABLET ER
In Gastroesophageal reflux disease (Acid reflux)
Some simple lifestyle changes can help reduce the symptoms of GERD. Think about what foods trigger heartburn and try to avoid them; eat smaller, more frequent meals; try to lose weight if you are overweight and try to find ways to relax. Do not eat within 3-4 hours of going to bed. click here : Cintapro OD
In Indigestion
SIDE EFFECTS OF CINTAPRO-OD TABLET ER
Common side effects of Cintapro-OD
- Headache
- Nausea
- Diarrhea
HOW TO USE CINTAPRO-OD TABLET ER
HOW CINTAPRO-OD TABLET ER WORKS
SAFETY ADVICE

Alcohol

Pregnancy

Breast feeding

Driving

Kidney

Liver
Reviews
There are no reviews yet.